JUNO - Juno Therapeutics Inc
This page shows which of the focused investors we track hold JUNO and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2014 it was held by 2 managers with an aggregate reported value of $6.27M, which is 0.00% of the combined portfolio.
As of Q4 2014, 2 tracked institutional managers held JUNO (Juno Therapeutics Inc) with an aggregate reported value of $6.27M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades JUNO — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2014
- Ticker
- JUNO
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Stanley Druckenmiller - Duquesne Family Office LLC | 0.36% | New | 70,000 | $3.66M |
| 2 | Leon Cooperman - Leon Cooperman | 0.04% | New | 50,000 | $2.61M |
Loading holder history for JUNO…